Rion is a clinical-stage biotechnology company That develops exosome therapeutics. Purified Exosome ProductTM (PEPTM) from Rion is a potent, useful, and easily available regenerative medicine. Research by Rion and its scientific partners has demonstrated the potential of PEP to repair a variety of injured tissue, including tendons, muscles, andskin. The goal of Rion is to spread the use of clinically effective regenerative medicine throughout the world.

Biotechnology

Rion

Atta Behfar

Laura Tucker (she, her)

Tony Wittnebel

Maureen Merrifield

Lindsey Rislow

Kevin Schiller

Chris Paradise, Ph.D.

Ben Boedeker, DVM, MD,PhD, MBA

Anna Eckerman

Alisa Lask

Alex Suihkonen

Leadership Team

Directors and Senior Managers

Research and Development Team

Teams at Rion

Leadership Team

Directors and Senior Managers

Research and Development Team